Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UNITED THERAPEUTICS (UTHR) Long-Term Deferred Tax: 2009-2025

Historic Long-Term Deferred Tax for UNITED THERAPEUTICS (UTHR) over the last 16 years, with Sep 2025 value amounting to $354.9 million.

  • UNITED THERAPEUTICS's Long-Term Deferred Tax fell 9.21% to $354.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $354.9 million, marking a year-over-year decrease of 9.21%. This contributed to the annual value of $458.4 million for FY2024, which is 16.11% up from last year.
  • Latest data reveals that UNITED THERAPEUTICS reported Long-Term Deferred Tax of $354.9 million as of Q3 2025, which was down 22.21% from $456.2 million recorded in Q2 2025.
  • UNITED THERAPEUTICS's Long-Term Deferred Tax's 5-year high stood at $458.4 million during Q4 2024, with a 5-year trough of $261.9 million in Q4 2021.
  • Its 3-year average for Long-Term Deferred Tax is $388.8 million, with a median of $394.8 million in 2023.
  • Its Long-Term Deferred Tax has fluctuated over the past 5 years, first grew by 25.12% in 2022, then dropped by 9.21% in 2025.
  • UNITED THERAPEUTICS's Long-Term Deferred Tax (Quarterly) stood at $261.9 million in 2021, then increased by 25.12% to $327.7 million in 2022, then climbed by 20.48% to $394.8 million in 2023, then climbed by 16.11% to $458.4 million in 2024, then dropped by 9.21% to $354.9 million in 2025.
  • Its Long-Term Deferred Tax stands at $354.9 million for Q3 2025, versus $456.2 million for Q2 2025 and $456.6 million for Q1 2025.